Narayan Prabhu

2021

In 2021, Narayan Prabhu earned a total compensation of $437.1K as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 865% increase compared to previous year.

Compensation breakdown

Option Awards$162,134
Salary$275,000
Total$437,134

Prabhu received $275K in salary, accounting for 63% of the total pay in 2021.

Prabhu also received $162.1K in option awards.

Rankings

In 2021, Narayan Prabhu's compensation ranked 10,996th out of 12,406 executives tracked by ExecPay. In other words, Prabhu earned more than 11.4% of executives.

ClassificationRankingPercentile
All
10,996
out of 12,406
11th
Division
Manufacturing
4,845
out of 5,492
12th
Major group
Chemicals And Allied Products
2,165
out of 2,368
9th
Industry group
Drugs
1,926
out of 2,089
8th
Industry
Pharmaceutical Preparations
1,422
out of 1,536
7th
Source: SEC filing on October 11, 2022.

Prabhu's colleagues

We found two more compensation records of executives who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2021.

2021

Laxminarayan Bhat

REVIVA PHARMACEUTICALS HOLDINGS

Chief Executive Officer

2021

Marc Cantillon

REVIVA PHARMACEUTICALS HOLDINGS

Chief Medical Officer

News

You may also like